Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 2
2006 1
2007 3
2008 2
2009 2
2010 3
2011 1
2012 5
2013 1
2014 2
2015 2
2016 3
2017 2
2018 3
2019 14
2020 6
2021 12
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.
Massimino M, Stella S, Tirrò E, Pennisi MS, Stagno F, Vitale SR, Romano C, Tomarchio C, Parrinello NL, Manzella L, Di Raimondo F, Vigneri P. Massimino M, et al. Among authors: stella s. Onco Targets Ther. 2023 Oct 3;16:803-816. doi: 10.2147/OTT.S413825. eCollection 2023. Onco Targets Ther. 2023. PMID: 37807980 Free PMC article.
A case of high-risk AML in a patient with advanced systemic mastocytosis.
Fazio M, Vetro C, Markovic U, Duminuco A, Parisi M, Maugeri C, Mauro E, Parrinello NL, Stagno F, Villari L, Triolo AM, Stella S, Palumbo GA, Di Raimondo F, Romano A, Zanotti R. Fazio M, et al. Among authors: stella s. Clin Case Rep. 2023 Jul 17;11(7):e7134. doi: 10.1002/ccr3.7134. eCollection 2023 Jul. Clin Case Rep. 2023. PMID: 37469366 Free PMC article.
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.
Stella S, Vitale SR, Massimino M, Motta G, Longhitano C, Lanzafame K, Martorana F, Fazzari C, Vecchio GM, Tirrò E, Inzerilli N, Carciotto R, Manzella L, Caruso M, Vigneri P. Stella S, et al. Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):464-476. doi: 10.21873/cgp.20333. Cancer Genomics Proteomics. 2022. PMID: 35732329 Free PMC article.
A Treatment-free Interval Allowed by Ponatinib as Fourth-line Therapy.
Bulla A, Markovic U, Bellofiore C, Stella S, Conticello C, DI Raimondo F, Stagno F. Bulla A, et al. Among authors: stella s. Cancer Diagn Progn. 2021 Mar 3;1(1):19-22. doi: 10.21873/cdp.10003. eCollection 2021 Mar-Apr. Cancer Diagn Progn. 2021. PMID: 35399694 Free PMC article.
75 results